Cost-Effectiveness and Formulary Evaluation: Imaginary Worlds and Entresto Claims in Heart Failure
The Program in Social and Administrative Pharmacy at the University of Minnesota recently released its proposed guidelines for formulary evaluation. The guidelines were focused on ensuring that comparative claims made for pharmaceutical products and devices rested on a credible evidence base. The ar...
Main Author: | Paul C Langley |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2016-09-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/449 |
Similar Items
-
Combined therapy with dapagliflozin and entresto offers an additional benefit on improving the heart function in rat after ischemia-reperfusion injury
by: Sheung-Fat Ko, et al.
Published: (2023-06-01) -
Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
by: Anuraag R. Kansal, et al.
Published: (2016-05-01) -
Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event
by: Michael M. Givertz, et al.
Published: (2021-06-01) -
In hospital costs of acute heart failure patients in the Czech Republic
by: Ondrackova Barbora, et al.
Published: (2009-12-01) -
Cost analysis of chronic heart failure management in Malaysia: A multi-centred retrospective study
by: Siew Chin Ong, et al.
Published: (2022-11-01)